Dual-Detector Radioisotope Infusion for Eluate Activity Separation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing systems for generating and delivering radiopharmaceuticals, such as rubidium-82, lack the ability to accurately measure and distinguish between the activity levels of the desired radioisotope and contaminating isotopes, particularly strontium-82, which can lead to unsafe and inaccurate dosing in nuclear medicine procedures.

Innovation Solution

A dual-detector system comprising a beta detector and a gamma detector is used to measure beta and gamma emissions, respectively, from radioactive eluate generated by a radioisotope generator, allowing for precise determination of the activity levels of rubidium-82 and potential contaminants like strontium-82, ensuring safe and accurate infusion into patients.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If a single detector is used to measure radioisotope activity, then the device complexity is reduced, but the measurement precision deteriorates because it cannot distinguish between different radioisotopes

Engineering Contradiction:
Improveradioisotope activity level measurementVSAvoiddetector system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection system is segmented into multiple specialized detectors: a beta detector for measuring beta emissions from rubidium-82, a gamma detector for measuring gamma emissions from strontium-82 contaminants, and a dose calibrator for overall activity measurement. Each detector targets specific radiation types from specific isotopes, enabling precise differentiation and measurement that a single detector cannot achieve.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary processing system that receives signals from multiple detectors and integrates the data. This intermediary system correlates beta detector signals with rubidium-82 activity, gamma detector signals with strontium-82 contamination, and dose calibrator readings with total activity, thereby resolving the complexity of multi-detector data integration while maintaining high measurement precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If multiple detectors are used to measure different radioisotopes, then the measurement precision improves, but the device complexity increases

Engineering Contradiction:
Improveradioisotope activity level measurementVSAvoiddetector system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection system is designed with multi-functionality where the controller integrates multiple detection functions into a unified platform. The system can selectively activate different detector combinations based on the specific measurement needs - using beta detector for rubidium-82, gamma detector for strontium-82, or both together for comprehensive analysis - thereby managing complexity through flexible, situation-appropriate operation.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system implements feedback mechanisms where the controller continuously monitors readings from all detectors and adjusts measurements based on detected radioisotope levels. When strontium-82 contaminants are detected by the gamma detector, the system provides feedback to alert operators and can adjust the eluate processing parameters, creating a closed-loop system that manages complexity through intelligent response to measurements.

Inventive Principle:
Principle #23Feedback

3Reliability

If radioisotope activity is not accurately measured, then the ease of operation is improved by simplifying the measurement process, but the reliability deteriorates due to unsafe contaminant infusion

Engineering Contradiction:
Improvepatient safetyVSAvoidmeasurement process
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system performs preliminary measurements of radioisotope activity and contaminant levels before the eluate is approved for patient infusion. The beta detector and gamma detector conduct initial screenings to ensure rubidium-82 activity is within therapeutic ranges and strontium-82 contaminants are below safety thresholds, preventing unsafe infusions before they occur and building reliability into the process early.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The controller provides real-time feedback to operators regarding measured radioisotope activity levels and contaminant presence. When measurements indicate unsafe conditions - such as excessive strontium-82 contamination or insufficient rubidium-82 activity - the system immediately alerts operators and prevents infusion, thereby ensuring patient safety while maintaining operational simplicity through automated monitoring and decision support.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dual-detector system provides enhanced accuracy in measuring radioisotope activity levels, preventing the infusion of unsafe contaminants and ensuring the safety and efficacy of radiopharmaceutical delivery during diagnostic imaging procedures.

Implementation Method 1

A beta detector can measure beta emissions caused by radioactive beta decay. During beta decay, a beta particle that is either an electron or a positron is emitted from an atomic nucleus.

Methodology Applied
Scientific EffectBeta decay: Radioactive Decay

Implementation Method 2

The gamma detector can measure gamma emissions or photons caused by radioactive gamma decay. During gamma decay, a stream of high-energy photons may be emitted from an atomic nucleus, providing detectable gamma rays.

Methodology Applied
Scientific EffectGamma decay: Radioactive Decay

Data Source

PatentEP4420685B1Systems and techniques for generating, infusing, and controlling radioisotope delivery
Publication Date: 2026.01.28 BRACCO DIAGNOSTICS INC
  • EP4420685B1 patent drawingFigure 1
  • EP4420685B1 patent drawingFigure 2
  • EP4420685B1 patent drawingFigure 3

AI summary

An infusion system may include a strontium-rubidium radioisotope generator that generates a radioactive eluate via elution, a beta detector, a gamma detector, and a controller. The beta detector and the gamma detector may be positioned to measure beta emissions and gamma emissions, respectively, emitted from the radioactive eluate. In some examples, the controller is configured to determine an activity of rubidium in the radioactive eluate based on the beta emissions measured by the beta detector and determine an activity of strontium in the radioactive eluate based on the gamma emissions measured by the gamma detector.